APOLIPOPROTEIN A-I (APO A-I)

GUDID 05055273209211

RANDOX LABORATORIES LIMITED

Apolipoprotein A-I (Apo A1) IVD, kit, nephelometry/turbidimetry
Primary Device ID05055273209211
NIH Device Record Keyaa226464-968e-4517-b744-b3e26964ec47
Commercial Distribution StatusIn Commercial Distribution
Brand NameAPOLIPOPROTEIN A-I (APO A-I)
Version Model NumberLP8007
Company DUNS227530649
Company NameRANDOX LABORATORIES LIMITED
Device Count1
DM Exemptfalse
Pre-market Exempttrue
MRI Safety StatusLabeling does not contain MRI Safety Information
Human Cell/Tissue Productfalse
Device Kittrue
Device Combination Productfalse
Single Usetrue
Lot Batchtrue
Serial Numberfalse
Manufacturing Datefalse
Expiration Datetrue
Donation Id Numberfalse
Contains Natural Rubber Latexfalse
Labeled No Natural Rubber Latexfalse
RX Perscriptionfalse
OTC Over-The-Counterfalse

Device Identifiers

Device Issuing AgencyDevice ID
GS105055273209211 [Primary]

FDA Product Code

MSJApolipoproteins

Sterilization

Steralize Prior To Usefalse
Device Is Sterilefalse

Device Entry Metadata

Public Version StatusNew
Device Record StatusPublished
Public Version Number1
Public Version Date2019-06-11
Device Publish Date2019-06-03

Devices Manufactured by RANDOX LABORATORIES LIMITED

05055273219951 - ESSENTIAL PACKAGE SAMPLE COLLECTION KIT (USA) 2024-02-07 The Blood Sample Collection Kit is intended for use in the collection and transport of a blood sample, taken by a trained phlebo
05055273219968 - EXTENDED PACKAGE SAMPLE COLLECTION KIT (USA) 2024-02-07 The Blood Sample Collection Kit is intended for use in the collection and transport of a blood sample, taken by a trained phlebo
05055273219999 - EXTENDED PACKAGE SAMPLE COLLECTION KIT (USA U60)2024-02-07 The Blood Sample Collection Kit is intended for use in the collection and transport of a blood sample, taken by a trained phlebo
05055273218480 - BNP CONTROLS FOR BECKMAN (BNP CONTROL)2023-12-29 The BNP Controls for Beckman (CQ10520) are intended for use with in vitro diagnostic assays for the quantitative determination o
05055273218497 - BNP CONTROLS FOR ABBOTT (BNP CONTROL)2023-12-29 The BNP Controls for Abbott (CQ10521) are intended for use with in vitro diagnostic assays for the quantitative determination of
05055273218725 - XANTHOCHROMIA POSITIVE CONTROL (XANTHOCHROMIA )2023-12-29 The Xanthochromia Positive Control is intended for use with in vitro diagnostic assays for the quantitative determination of Bil
05055273218732 - XANTHOCHROMIA NEGATIVE CONTROL (XANTHOCHROMIA )2023-12-29 The Xanthochromia Negative Control is intended for use with in vitro diagnostic assays for the quantitative determination of Bil
05055273218992 - PRE-ECLAMPSIA CONTROL LEVEL 32023-12-29 The Pre eclampsia Control Level 3 is intended for use with in vitro diagnostic assays for the quantitative determination of plac

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.